We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FGEN market cap is 40.46M. The company's latest EPS is USD -2.8206 and P/E is -0.14.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 40.13M | 27.14M | 55.9M | 50.64M | 46.33M |
| Operating Income | -63.48M | -54.2M | -31.06M | -10.92M | -16.78M |
| Net Income | -63.62M | -56.23M | -32.93M | -15.54M | -17.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 256.58M | 176.32M | 235.31M | 140.73M | 147.75M |
| Operating Income | -89.31M | -192.08M | -287.52M | -299.45M | -281.82M |
| Net Income | -76.97M | -189.29M | -290.02M | -293.65M | -284.23M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 460.43M | 423.53M | 365.87M | 293.2M | 264.42M |
| Total Liabilities | 575.63M | 585.73M | 552.02M | 483.58M | 466.12M |
| Total Equity | -136.68M | -183.68M | -207.64M | -211.85M | -223.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 857.4M | 826.84M | 773.82M | 610.09M | 423.53M |
| Total Liabilities | 321.99M | 385.39M | 544.71M | 611.57M | 585.73M |
| Total Equity | 535.41M | 441.45M | 229.11M | -1.48M | -183.68M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -296.7M | -315.02M | -59.29M | -99.16M | -107.53M |
| Investing | 143.42M | 153.66M | 51.28M | 123.52M | 124.27M |
| Financing | 123M | 122.75M | -165k | -133k | -260k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -78.71M | 81.6M | -82.23M | -145.93M | -315.02M |
| Investing | 120.02M | 452.49M | -426.97M | 89.12M | 153.66M |
| Financing | -4.3M | 13.34M | -563k | 46.78M | 122.75M |
| Market Cap | 40.46M |
| Price to Earnings Ratio | -0.14 |
| Price to Sales Ratio | 0.27 |
| Price to Cash Ratio | 0.35 |
| Price to Book Ratio | -0.25 |
| Dividend Yield | - |
| Shares Outstanding | 100.77M |
| Average Volume (1 week) | 1.36M |
| Average Volume (1 Month) | 8.33M |
| 52 Week Change | -77.69% |
| 52 Week High | 2.80 |
| 52 Week Low | 0.18 |
| Spread (Intraday) | 0.01 (1.78%) |
| Company Name | FibroGen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.fibrogen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
